Day: May 19, 2022

Categories
MENA Press Releases

Mainz Biomed & Dante Labs Announce Partnership for the Commercialization of ColoAlert in Europe and the United Arab Emirates (UAE)

  • Dante Labs is a Global Leader in Genomics and Precision Medicine
  • Mainz is Exclusively Focused on Developing Next Generation Diagnostics for the Early Detection of Cancer

BERKELEY, Calif. and MAINZ, Germany and NEW YORK, May 19, 2022 (GLOBE NEWSWIRE) — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer and Dante Labs, a global leader in genomics and precision medicine, announced today a partnership for the commercialization of ColoAlert in Italy and the United Arab Emirates (UAE). ColoAlert is Mainz’s flagship product, a highly efficacious and easy to use at-home detection test for colorectal cancer (CRC).

Dante Labs is a global leader in genome sequencing with a product development and commercial franchise focused on providing personalized preventive healthcare solutions by leveraging its robust databases and proprietary software platform to offer next-generation diagnostic tools direct to consumers and healthcare professionals. Inherent to Dante Lab’s business model is managing state-of-the-art genomic sequencing laboratories in multiple international regions, and operating a robust e-commerce platform.

“As a young company with the goal of bringing to market important diagnostic tools to help treat and prevent cancer indications, it’s an absolute pleasure to partner with an industry leader such as Dante Labs,” commented Guido Baechler, Chief Executive Officer of Mainz Biomed. “Our differentiated commercial plan of partnering with third-party laboratories for test kit processing versus the traditional methodology of operating a single facility requires alliances with like-minded companies such as Dante Labs, who share our passion for forward-thinking diagnostic test development and marketing strategies.”

The partnership will first launch ColoAlert in Italy and UAE using Dante’s various established commercial channels. Samples will initially be processed at Mainz’s in-house facility and then Dante will purchase Mainz’s CE-IVD polymerase chain reaction (PCR) assay kits and transition all test processing to Dante’s wholly-owned automated genomic sequencing laboratories in Italy (Europe) and Dubai (UAE) to offer localized service and support.

“We are excited by the opportunity to align with Mainz and represent ColoAlert in these initial markets,” commented Andrea Riposati, Chief Executive Officer of Dante Labs. “Both the product and the Company mirror our mission to develop and market top-tier preventive health solutions and use new channels to make innovative tests available to more patients around the world. With the launch of our enhanced ecommerce platforms for advanced diagnostics, ColoAlert is an amazing product to deliver more personalized medicine.”

ColoAlert is currently marketed across Europe, and the partnership with Dante Labs marks the test’s initial launch in the Middle East. Mainz will continue to develop commercial and R&D partnerships with companies that lead the field of health screening with a particular focus on stool diagnostics.

About ColoAlert

ColoAlert detects colorectal cancer (CRC) via a simple-to-administer test with a sensitivity and specificity nearly as high as the invasive colonoscopy*. The test utilizes proprietary methods to analyze cell DNA for specific tumor markers combined with the fecal immunochemical test (FIT) and is designed to detect tumor DNA and CRC cases in their earliest stages. The product is CE-IVD marked (complying with EU safety, health and environmental requirements) and is transitioning to compliance with IVDR. The product is commercially available in a selection of countries in the Europe Union. Mainz Biomed currently distributes ColoAlert through a number of clinical affiliates. Once approved in the U.S., the Company’s commercial strategy is to establish scalable distribution through a collaborative partner program with regional and national laboratory service providers across the country.

*Dollinger MM et al. (2018)

About Colorectal Cancer

Colorectal cancer (CRC) is the second most lethal cancer in the U.S. and Europe, but also the most preventable with early detection providing survival rates above 90%. Annual testing costs per patient are minimal, especially when compared to late-stage treatments of CRC which cost patients an average of $38,469 per year. The American Cancer Society estimated that in 2021 there were approximately 149,500 new cases of colon and rectal cancer in the U.S. with 52,980 resulting in death. Recent FDA decisions suggest that screening with stool DNA tests such as ColoAlert in the US should be conducted once every three years starting at age 45. Currently there are 112 million Americans aged 50+, a total that is expected to increase to 157 million within 10 years. Appropriately testing these US-based 50+ populations every three years as prescribed equates to a US market opportunity of approximately $3.7 Billion per year.

About Mainz Biomed N.V.

Mainz Biomed develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The Company’s flagship product is ColoAlert, an accurate, non-invasive, and easy-to-use early detection diagnostic test for colorectal cancer. ColoAlert is currently marketed across Europe with FDA clinical study and submission process intended to be launched in the first half of 2022 for U.S. regulatory approval. Mainz Biomed’s product candidate portfolio includes PancAlert, an early-stage pancreatic cancer screening test based on Real-Time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples, and the GenoStick technology, a platform being developed to detect pathogens on a molecular genetic basis.

For more information please visit www.mainzbiomed.com

For media enquiries, please contact press@mainzbiomed.com

For investor enquiries, please contact ir@mainzbiomed.com

About Dante Labs
Dante Labs is a global genomic information company building and commercializing a new class of transformative health and longevity applications based on whole genome sequencing and AI. The Company uses its platform to deliver better patient outcomes from diagnostics to therapeutics with assets including one of the largest private genome databases with research consent, proprietary software designed to unleash the power of genomic data at scale and proprietary processes which enable an industrial approach to genomic sequencing.

Contact:

Laura D’Angelo
VP of Investor Relations
ir@dantelabs.com
+39 0862 191 0671
www.dantelabs.com

Forward-Looking Statements

Certain statements made in this press release are “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “anticipate”, “believe”, “expect”, “estimate”, “plan”, “outlook”, and “project” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements reflect the current analysis of existing information and are subject to various risks and uncertainties. As a result, caution must be exercised in relying on forward-looking statements. Due to known and unknown risks, actual results may differ materially from the Company’s expectations or projections. The following factors, among others, could cause actual results to differ materially from those described in these forward-looking statements: (i) the failure to meet projected development and related targets; (ii) changes in applicable laws or regulations; (iii) the effect of the COVID-19 pandemic on the Company and its current or intended markets; and (iv) other risks and uncertainties described herein, as well as those risks and uncertainties discussed from time to time in other reports and other public filings with the Securities and Exchange Commission (the “SEC”) by the Company. Additional information concerning these and other factors that may impact the Company’s expectations and projections can be found in its initial filings with the SEC, including its Prospectus filed on October 12, 2021 and amended on October 25, 2021 and November 1, 2021 as well as the Prospectus filed on January 21, 2022. The Company’s SEC filings are available publicly on the SEC’s website at www.sec.gov. Any forward-looking statement made by us in this press release is based only on information currently available to Mainz Biomed and speaks only as of the date on which it is made. Mainz Biomed undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise, except as required by law.

Categories
Africa MENA Pakistan Press Releases South Africa

Advance Local is New Sophi.io Customer

TORONTO, May 18, 2022 (GLOBE NEWSWIRE) — Advance Local, one of the largest media groups in the United States operating 10 leading news and information organizations and reaching 55 million people monthly, has quadrupled their subscription goal using Sophi Content Paywall Engine. Faced with advertising pressures exacerbated by the Coronavirus, Advance Local increased subscription conversions 45% using Sophi.io, an AI-powered automation, optimization and prediction platform developed by The Globe and Mail. Their success with Sophi has also earned them a spot as a finalist in the Digiday Media Awards, announced this week.

Neil Katz, Chief Customer Officer at Advance Local, said, “We wanted to see how much farther Sophi could take us, so we tested Sophi Content Paywall on one of our largest sites. The results were transformative. We were hoping for a 10% lift in conversion rate and Sophi delivered four times that result. We’re continuing to roll out Sophi solutions across more of our sites as we speak.”

Advance started using Sophi Content Paywall Engine on one of its largest sites, cleveland.com, to get better insights into the value of their content and fuel their new subscription business. The technology uses advanced natural language processing (NLP) to analyze every piece of content and select which articles to put behind a paywall. It picks only those articles where the subscription revenue opportunity outweighs the advertising revenue forgone.

During an experiment where Advance could see how Sophi performed side by side with their existing paywall, Sophi presented roughly the same amount of paywalls and generated a 45% lift in the total conversion rate, while also uncovering pockets of content that editors didn’t anticipate would generate subscriptions.

John Hassell, Senior Vice President and Editorial Director at Advance Local, said, “We wanted to see if Sophi’s content paywall could increase subscriber acquisition by 10% and it blew that goal out of the water. We’re feeling good about the platform and the way it is showing us just how valuable our editorial content is to our audience.”

Advance Local is also a finalist in the Digiday Media Awards, in the category of Best Subscription or Membership Product, for their work using Sophi Content Paywall Engine.

“Advance Local is an incredibly innovative organization that we’ve watched push the boundaries and we’re very excited to be working with them,” said Mike O’Neill, Co-Founder and CEO of Sophi.io. “We’re seeing great value come from the content paywall they’ve implemented and we’re excited to introduce some other cutting edge technology into this very strong brand.”

About Advance Local

Advance Local (www.advancelocal.com) is one of the largest media groups in the United States. It operates 10 leading news and information organizations and reaches 55 million people monthly across multiple platforms with its high-quality journalism. They are dedicated to unrivaled local journalism that improves the lives of millions of people.

About Sophi.io

Sophi.io (https://www.sophi.io) was developed by The Globe and Mail to help content publishers make important strategic and tactical decisions. It is a suite of AI and ML-powered automation, optimization and prediction solutions that include Sophi Site Automation, Sophi for Paywalls and Sophi for First Party Data. Sophi also powers one-click automated laydown of template-free print publishing. Sophi is designed to improve the metrics that matter most to your business, such as subscriber retention and acquisition, engagement, recency, frequency and volume.

Contact Us

Jamie Rubenovitch
Head of Marketing, Sophi.io
The Globe and Mail        
jrubenovitch@globeandmail.com
416-585-3355
Categories
MENA Press Releases

Openbravo signs a distribution contract with Hardis Group to accelerate retailers’ unified commerce strategies

LILLE, France, May 19, 2022 /PRNewswire/ — Openbravo, the Spanish vendor of a unified commerce platform for agile and innovative commerce, is implementing an ambitious indirect distribution strategy to support its growth in France, especially in the mid-market segment. The company has signed a major partnership with Hardis Group, IT consulting and services company, integrator, logistics software vendor and a specialist in the acceleration of digital commerce in B2B, B2C and D2C. Hardis Group will act as integrator and distributor of Openbravo’s unified commerce platform for customer experience improvement.

Hardis Group Logo

After a period of constant development following the opening of its French subsidiary 4 years ago and with a growing portfolio of references, Openbravo is now opening an indirect sales channel with partners offering high added value to establish its presence on the national territory. Openbravo provides software development and hosting, while its partners manage integration and consulting.

Hardis Group recently launched a Digital Commerce activity and aims to support companies across their entire digital commerce strategy. The group offers ‘end-to-end’ support, from omnichannel strategy consulting to the integration and operation of ‘composable’ information systems to accelerate digital commerce. Thanks to the Openbravo’s unified commerce platform, Hardis Group enables retailers to benefit from a fluid solution.

Openbravo Logo

Hardis Group has chosen Openbravo for its ability to provide an appropriate response to the retail challenges of omnichannel commerce to promote collaboration and to improve the customer experience. This partnership is also based on shared values such as allowing users to focus on the essentials (their business, agility and operational performance) thanks to intuitive mobile solutions. It has been formalized by signing a Business Alliance contract.

“Today, Openbravo directly manages key accounts and strategic retail accounts. In order to continue to address the mid-market, it was essential to rely on integrator partners with strong business expertise in retail. This partnership with Hardis is the concrete expression of a common desire, and the result of a fruitful collaboration on several projects” comments Christophe Dubuis, Sales Director for France and Northern Europe at Openbravo.

“Our teams are enthusiastic about the idea of taking on new challenges with Openbravo and are confident of the success of this collaboration, bringing together specialists with strong skills in a buoyant market. Openbravo provides real answers to the retailers and eCommerce players and allows us to propose the building blocks that were missing from our offer.” says Yohann Durand, Director of the Ile-de-France and North branch at Hardis Group.

About Openbravo

Openbravo is the software platform of choice for brands and retailers looking to accelerate their unified commerce strategy and increase the agility of their operations. It is a fully modular platform that integrates the online and offline channels and provides intelligent order management, a single, real-time view of customers and inventory, and a complete store solution to deliver more personalized and convenient experiences. It is an all-in-one cloud-based solution.

International clients such as BUT, Decathlon, Norauto, Sharaf DG, Toys ‘R’ Us Iberia and Zôdio prefer Openbravo, which is today used by more than 10,000 back office users and in more than 40,000 points of sale in more than 50 countries. To learn more, visit openbravo.com.

About Hardis

Hardis Group is an IT consulting and services company, Salesforce integrator and logistics software publisher with a mission to accelerate the transformation of commerce, the supply chain and information systems, particularly through cloud technologies. Its 1,235 employees support the strategic, organizational and technological transformations of companies throughout Europe, in order to develop their competitiveness, productivity and attractiveness.

Hardis Group had a turnover of 132.7 million euros in 2021. The company is in Grenoble (headquarters), Paris, Lyon, Lille, Nantes, Bordeaux, Madrid, Utrecht and Warsaw.

Logo – https://mma.prnewswire.com/media/1821118/Hardis_Group_Logo.jpg
Logo – https://mma.prnewswire.com/media/703504/Openbravo_Logo.jpg

Contact:
Xavier Places
Marketing Director
+34 607 676 568
xavier.places@openbravo.com

 

 

Categories
Arabic MENA Press Releases

‫تحرر JA Solar الوحدة الكهروضوئية من النوع N DeepBlue 4.0 X

بكين، 19 مايو 2022 / PRNewswire / — تحتفل JA Solar بحدث إطلاق منتجاتها الجديدة لعام 2022 في 18 مايو، مع إطلاق أول وحدة كهروضوئية من النوع n DeepBlue 4.0 X . يمثل هذا العرض الجديد المبتكر أول دخول للشركة في سوق المنتجات الكهروضوئية من النوع n .

JA Solar new product DeepBlue 4.0 X

استنادًا إلى 182 رقاقة، التي تتميز بسلسلة التوريد الأكثر نضجًا والتعرف على مستوى الصناعة، تتضمن سلسلة DeepBlue 4.0 X ثلاثة أنواع من الوحدات قابلة للتكيف مع أي سيناريو: وحدة مكونة من 54 خلية للأنظمة الكهروضوئية السكنية، و 72 خلية و 78 خلية للمشاريع الكهروضوئية التجارية والخدمية. اجتازت DeepBlue 4.0 X بالفعل اختبارات IEC 61215 و IEC 61730 وحصلت على شهادة TÜV SÜD ، كما اجتازت اختبار ضباب الملح والأمونيا والرمل والغبار، مما يثبت ملاءمتها عبر مختلف التطبيقات والبيئات.

بالإضافة إلى المزايا المرحلة من وحدات DeepBlue 3.0 النمطية، تدمج DeepBlue 4.0 X أحدث التقنيات من JA Solar ، بما في ذلك خلية Bycium+ ، حيث يمكن أن تصل كفاءة الإنتاج الكتلي إلى أكثر من 24.8% بسبب ركيزتها وبنيتها عالية الجودة. أيضًا، تم تجهيز DeepBlue 4.0 X بتقنية التغليف عالية الكثافة الحاصلة على براءة اختراع GFI (التوصيل البيني المرن بدون فجوة)، حيث يتعامل تصميم الشريط المستدير مع المعالجة المؤقتة ومواد التغليف المحسنة مع الإجهاد الميكانيكي عند وصلات الخلايا البينية وبالتالي القضاء على خطر التكسير الدقيق. معًا، تجلب هذه موثوقية أعلى وإنتاجية أعلى للطاقة إلى DeepBlue 4.0 X ، مع أقصى طاقة تصل إلى 625 واط وكفاءة تصل إلى 22.4%.

 وفقًا لـ Kun Tang ، مدير قسم تكنولوجيا المنتجات في JA Solar ، تعمل JA Solar على التكنولوجيا من النوع n لسنوات، وبعد الاستثمار المستمر في البحث والتطوير والتجريب، أصبحت جاهزة أخيرًا للإنتاج الضخم. للتحقق من أداء توليد الطاقة للمنتج، أطلقت JA Solar و TÜV NORD اختبارًا لعائد الطاقة لمدة عام واحد (فبراير 2021 – فبراير 2022) في مركز اختبار الفولطا الضوئية الصيني، قاعدة ينشوان (شمال غرب الصين). تُظهر النتائج أن إنتاجية الطاقة للوحدة النمطية من النوع n بناءً على خلايا Bycium + أعلى بنسبة 3.9% من تلك الخاصة بوحدات p-PERC النمطية. وفقًا لبيانات محاكاة نظام JA Solar الكهروضوئي، مقارنة بالوحدات من النوع p ، فإن خفض تكلفة BOS لـ DeepBlue 4.0 X يصل إلى 2.1%، و LCOE عند 4.6%، مما يزيد من IRR ويجلب المزيد من القيمة للعميل.

وقال السيد شينوي نيو، عضو مجلس الإدارة ونائب الرئيس الأول لشركة JA Solar ، “لقد أصبح تطوير الحلول منخفضة الكربون والحلول الخضراء مهمة عالمية رئيسية. وباعتبارها واحدة من أكثر مصادر الطاقة المتجددة مرونة وفعالية من حيث التكلفة، أصبحت الطاقة الكهروضوئية قوة مهمة في تعزيز الحياد الكربوني. من النوع p إلى النوع n ، من DeepBlue 3.0 إلى DeepBlue 4.0 X ، تلتزم JA Solar دائمًا بمفهوم تصميم المنتج “الموجه للعملاء”. ونحن نحاول دائما تحسين أداء الوحدات الكهروضوئية في توليد الطاقة من أجل خلق قيمة أكبر للعملاء وتعزيز تطبيق الطاقة الكهروضوئية على نطاق عالمي للاضطلاع بدور أكبر في عملية الحياد الكربوني العالمي”.

الصورة –  https://mma.prnewswire.com/media/1820491/JA_Solar_new_product_DeepBlue_4_0_X.jpg

Categories
General

Norwegian Embassy celebrates National Day

On the occasion of Norway’s National Day, the Norwegian Embassy in Amman on Wednesday held a reception for its friends, partners, and counterparts at the ambassador’s Residence.

During the ceremony, Norwegian Ambassador to Jordan Espen Lindbeck emphasized the strong political and economic cooperation between Norway and Jordan, describing Jordan as an important partner to resolve and prevent conflicts in the Middle East and enhance stability in the region.

Lindbeck also highlighted the close ties between the two Kingdoms’ Royal Families, as shown during the recent visit of the His Majesty King Abdallah to Norway in March, two years after the Norwegian state visit by their Majesties King Harald and Queen Sonja to Jordan.

The ambassador voiced Norway’s appreciation for Jordan’s hospitality towards hosting of refugees and reiterating Norway’s commitment to its support to the protracted refugee crisis.

Lindbeck also pointed to the coordination between the two countries on issues related to peace and security in the Middle East and globally, especially as Norway currently is an elected member of the security council.

In addition, Lindbeck pointed out that they are working to increase the trade and economic cooperation between Norway and Jordan, and for Norwegian businesses to be more engaged in the Jordanian market and use this as a hub for the broader region. He also underlined the close defense collaboration between the two-armed forces, and that an agreement of joint exercises has been signed.

Lastly, Lindbeck thanked for the warm hospitality he had received in Jordan during his first year as ambassador, saying: “It has been a true privilege during my first year here in Amman to discover how many bonds that ties our two small monarchies – with longstanding traditions for engaging in dialogue. And we are all looking forward to continued and renewed collaboration”.

The Norwegian National Day celebrates the establishment of the Norwegian Constitution in 1814 – today one of the oldest written constitutions still in use.

SOURCE: JORDAN NEWS AGENCY

Categories
General

Jordan co-chairs 5th UfM ministerial meeting

Jordan and the European Union on Wednesday co-chaired the 5th ministerial meeting of the Union for the Mediterranean (UfM) on employment and work, hosted by Morocco.

Jordan’s representative, Minister of Labor Nayef Istitieh, said that the 2-day ministerial meeting focused on employment and employability of the most vulnerable, especially among youth and women.

“The ministers emphasized on sharing best practices of economic recovery from the COVID-19 crisis, and discussed the most pressing labor market challenges in the Euro-Mediterranean region,” he said.

Istitieh indicated that finding employment opportunities in light of the persisting negative effects of COVID-19 has become a major challenge not only for Jordan, but for all countries of the southern Mediterranean. “This calls for redoubled efforts in coordination between the two sides of the Mediterranean to reduce unemployment rates, with a focus on vocational training and lifelong learning,” he added.

On the sidelines of the ministerial meeting, the minister held separate meetings with a number of Arab and European labor ministers, as well as representatives of international organizations, and discussed Jordan’s need to develop its vocational and technical training system, increase job opportunities and promote the integration of women into the labor market.

SOURCE: JORDAN NEWS AGENCY

Categories
General

Monkeypox cases detected in Spain

Health authorities in Spain announced on Thursday they had identified the first case of a rare monkeypox infection, after outbreaks in Portugal and the United Kingdom.

According to the Guardian newspaper, a nationwide alert of a possible outbreak had been issued to guarantee a swift, coordinated and timely response, after 23 people developed compatible symptoms.

Early symptoms of monkeypox include fever, headache, muscle aches, swollen lymph nodes and chills. A rash that can look like chickenpox or syphilis can also develop and spread from the face to other parts of the body.

SOURCE: JORDAN NEWS AGENCY

Categories
General

Amman court convicts US company with money laundering

An Amman anti-corruption commission on Thursday convicted a US company of money laundering and terrorist financing and a foreigner of fraud after they scammed the national carrier, Royal Jordanian (RJ), into paying them an amount of $356,000 that was supposed to go to an aircraft fuel supplier.

The Second Anti-corruption Commission with the Amman Magistrate Court also found seven RJ employees guilty of breach of duty and ordered them to pay damages of about $101,192. As for the foreign national, the court sentenced him to a one-year term after he was found guilty of fraud and money laundering.

Moreover, the court found the US company guilty of money laundering and terrorist financing and ordered it, along with the foreign national, to pay damages totaling $107,514.

In its verdict, the court said the US company and the foreigner used fake emails to access transfers that were supposed to go a company supplying RJ aircraft with fuel.

SOURCE: JORDAN NEWS AGENCY

Categories
General

JFDA delegation in Netherlands for food inspection cooperation

A delegation from the Food and Drug Administration (JFDA) has discussed with Dutch food safety officials prospects of joint cooperation between the two countries regarding food safety and control systems.

The delegation, led by JFDA Director-General Nizar Mheidat, has held talks with officials at the Netherlands Food and Consumer Product Safety Authority on issues related to pesticide residues and veterinary medicines control, border crossings control, the traceability of food, agricultural and animal products from farm to table and risk assessment of plant and animal products.

SOURCE: JORDAN NEWS AGENCY

Categories
General

German employment agency eyes Jordanian talents

Germany’s Federal Employment Agency (BA) on Thursday said that it is currently working on expanding cooperation with its Jordanian partners to attract Jordanian talents to work in Germany.

During a meeting with a number of Jordan Industry Chamber (JCI) Board Members, head of the BA International Department Markus Bircher said there is a high demand for qualified youth from various majors in the German labor market, noting that his country had launched the sustainable recruitment of nurses program (Triple Win) in Jordan, in cooperation with the German Agency for International Cooperation (GIZ), to provide job opportunities for Jordanians in the nursing sector.

He added that the program attracts talents from a number of countries, including Jordan, which was chosen after studying its educational process, noting that those who want to work in Germany have to pass a German language level test that should be accredited by the German authorities.

JCI’s Vice Chairman Ahmed Khodari stressed the importance of furthering cooperation with Germany to develop training programs for many industrial majors to cover the needs of the industry sector.

For his part, JCI’s Member of the Board of Directors Sa’ad Yassin valued German support for Jordan, commending the role of the German-Jordanian Economic Cooperation Office since its establishment eight years ago in advancing economic ties between the two countries and organizing forums and meetings.

He added that JCI seeks to promote Jordan as a country rich with human talents and resources. The chamber’s responsibility is to provide job opportunities for Jordanians, thus reducing unemployment percentages in the Kingdom, he added.

Director-General at JCI Nael Al-Husami noted coordination with the German-Jordanian Economic Cooperation Office to organize meetings that brought together the National Company for Training and Employment, the Vocational Training Corporation, the Technical and Vocational Skills Development Commission, syndicates of engineers, doctors, nurses, and pharmacists, and BA to discuss the employment of Jordanians in various sectors in Germany.

SOURCE: JORDAN NEWS AGENCY